Mycobacteria Registry Study: Prospective Observational Study in Austria
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLudwig Boltzmann Institute for Lung Health
About this trial
The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is:
What are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria?
Data from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.
Eligibility criteria
Qualifiers
patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection
individuals aged 18 years or older
written informed consent
Disqualifiers
to not comprehend and rightfully judge participation
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Ludwig Boltzmann Institute for Lung Health
Lead sponsor
Sigmund Freud PrivatUniversitat
Collaborator
Source ClinicalTrials.gov